Health Care & Life Sciences » Pharmaceuticals | Beijing Beilu Pharmaceutical Co. Ltd.

Beijing Beilu Pharmaceutical Co. Ltd.

Beijing Beilu Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.33
Market Cap
CNY4.42 B
Shares Outstanding
399.69 M
Public Float
289.04 M

Profile

Address
7/F, Blk A, Fenglan Intl Office Bldg
Beijing Beijing 100082
China
Employees -
Website http://www.beilu.com.cn
Updated 07/08/2019
Beijing Beilu Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical product. Its products cover contrast medium product, glimepiride, and anti-anxiety product. The contrast medium product includes ferric ammonium citrate, gadopentetate, and iohexol injection.

Financials

View All
Created with Highcharts 5.0.14Beijing Beilu Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values CNY Thousands.65 97165 97186 76886 76832 57932 57916 37916 379118 816118 816147 761147 761201320142015201620172018025k50k75k100k125k150k175k
Created with Highcharts 5.0.14Beijing Beilu Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values CNY Thousands.327 496327 496435 317435 317486 007486 007492 688492 688514 237514 237598 730598 7302013201420152016201720180100k200k300k400k500k600k700k

Dai Xue Wang
Chairman
Xu Wang
Vice Chairman & General Manager